Iterative Health

Iterative Health is a healthcare technology and services company focused on accelerating clinical research and improving patient outcomes. Founded in 2017, the company says its mission is to help bring life-changing therapies to patients sooner by combining clinical-trial expertise, operational capabilities, and technology. Its headquarters are in Cambridge, Massachusetts, with an additional headquarters location in New York, New York.

The company works with healthcare providers, research sites, biopharmaceutical sponsors, and contract research organizations (CROs). Its model connects clinical research with community-based care, aiming to broaden patient access to trials while helping sponsors and investigators conduct studies more efficiently. Iterative Health describes its site network as a performance-driven global network serving GI, hepatology, obesity, and cardiology research.

For provider partners and research sites, Iterative Health offers operational support intended to help practices build and grow clinical research programs. The company describes services that include research staff support and development, centralized operations, access to studies, and technology intended to support site workflows and patient enrollment. Its partnership approach is designed to integrate trials into community practices rather than limiting research access to academic centers.

For sponsors and CROs, the company provides access to research sites and operational capabilities across its therapeutic focus areas. Its stated services include site selection, study activation, patient enrollment support, and trial execution. Iterative Health positions this network and its specialized operational expertise as tools to reduce administrative burden, support predictable study delivery, and expand access to research populations.

Artificial intelligence is part of the company’s technology strategy. Iterative Health says it combines clinical-trial experience with AI-powered tools to support research teams and sponsors. The company’s earlier work also included applying AI and computer vision to gastroenterology and endoscopic analysis. Its current public positioning emphasizes using technology alongside site expertise and clinical operations to help studies move forward efficiently.

The company was founded with the goal of addressing gaps in healthcare and helping patients obtain needed treatments sooner. Its official company information highlights partnerships with provider networks, including GI Alliance, One GI, and US Heart & Vascular, to extend research across community practices. The company’s therapeutic focus spans gastrointestinal disease, hepatology, obesity, and cardiology, and it reports working with sponsors across the life-sciences ecosystem.

Iterative Health describes its values through the acronym G.R.I.T.: Growth, Responsibility, Impact, and Team. Its stated culture emphasizes learning and adaptability, ownership and high standards, focusing on meaningful work, and collaboration. The company says it seeks employees interested in advancing clinical research and expanding access to innovative therapies.